Coherus Oncology (CHRS) Invested Capital (2013 - 2026)
Coherus Oncology (CHRS) posted Invested Capital of $98.09 million for Q2 2026, down 37.4% from $156.69 million a year earlier and down 15.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Invested Capital (2013 - 2026) Analysis & Trends
For FY2025, Coherus Oncology's Invested Capital came in at $98.07 million.
- Annual Invested Capital shows a five-year compound annual growth rate of -22.7% (FY2020 to FY2025).
- In prior years, Coherus Oncology's Invested Capital was -$95.29 million in FY2024, $53.06 million in FY2023 (-50.9%), $108.07 million in FY2022 (-37.6%) and $173.24 million in FY2021 (-51.3%).
- Quarterly Invested Capital has run from a low of -$146.69 million in Q1 2025 to a high of $286.97 million in Q3 2021 over five years.
- The strongest year-over-year quarter for Invested Capital in the past five years was Q1 2024, with growth of 236.5%; the weakest was Q1 2023, with a decline of 76.4%.
- According to Business Quant data, Invested Capital for the three prior quarters was $115.77 million (Q1 2026), $98.07 million (Q4 2025) and $124.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 51.53 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 82.72 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 98.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.09 Mn |
| Mar 31, 2026 | 115.77 Mn |
| Dec 31, 2025 | 98.07 Mn |
| Sep 30, 2025 | 124.73 Mn |
| Jun 30, 2025 | 156.69 Mn |
| Mar 31, 2025 | -146.69 Mn |
| Dec 31, 2024 | -95.29 Mn |
| Sep 30, 2024 | -51.36 Mn |
| Jun 30, 2024 | -47.57 Mn |
| Mar 31, 2024 | 165.61 Mn |
| Dec 31, 2023 | 53.06 Mn |
| Sep 30, 2023 | 112.62 Mn |
| Jun 30, 2023 | 71.20 Mn |
| Mar 31, 2023 | 49.21 Mn |
| Dec 31, 2022 | 108.07 Mn |
| Sep 30, 2022 | 148.11 Mn |
| Jun 30, 2022 | 173.41 Mn |
| Mar 31, 2022 | 208.41 Mn |
| Dec 31, 2021 | 173.24 Mn |
| Sep 30, 2021 | 286.97 Mn |
API Access
Coherus Oncology Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();